Correction to: Acta Pharmacol Sin 2015;36:1085–98, https://doi.org/10.1038/aps.2015.42, published online 03 August 2015
The authors regretted to find the mis-representative images in Fig. 3a, c and Fig. 4a, c when re-read our previously published article Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro (https://doi.org/10.1038/aps.2015.42) in the journal of Acta Pharmacologica Sinica. The first mistake occurred due to the careless compilation when the authors tried to show the synergistic effect against tumor during figure presentation process. The second mistake occurred because the authors carelessly mixed up representative pictures of different magnification during microscopic observation of breast cancer cells after drugs treatments. The right Fig. 3a, c and Fig. 4a, c were provided below. Despite that this correction does not affect the results and conclusions of the aforementioned paper, all the authors still consent on the correction of this negligence. We apologize to the Editor and the readership of the journal for any inconvenience caused. Your thoughtful understanding is highly appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Qiao, H., Wang, Ty., Yan, W. et al. Author Correction: Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid in vitro. Acta Pharmacol Sin 40, 1127–1128 (2019). https://doi.org/10.1038/s41401-019-0232-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-019-0232-x